Abstract:
Introduction: The complex process between cancer invasion and stroma response is still being
elucidated, but is clear that cancer is a disease of more than just malignant cells. The tumor interstitial
fluid has an important role in initiating the immune response. Determining the composition of tumor
interstitial fluid can give us information about poor or good prognosis. Moreover, access to breast
cancer’s stroma permits us to identify the substances that can be used in early detection and monitoring
the disease activity. Our aim is to summarize the recent studies on peri-tumoral stroma and tumor
interstitial fluid compared to normal mammary gland structure and use the results for early diagnosis,
monitoring disease and maybe change the therapeutical targets.
Materials and Methods: The study represents a literature review and is based on state-of-theart
information colected from 12 articles on breast cancer development from PubMed.
Results: In comparison to normal mammary gland structure, in the peri-tumoral stroma of breast
cancer there are increased alpha smooth muscle actin, collagen IV, hyaluronan, fibroblast activated
protein, myeloid-derived suppressor cells, cancer Associated adipose and a variety of host cells including
macrophages and fibroblasts. Elevated expression of hyaluronan, tumor Associated macrophages,
vascular endothelial growth factor-A, myeloid-derived suppressor cells- tell us about a poor prognosis.
Numerous studies have demonstrated that inhibition of hyaluronan synthesis using 4-MU, tyrosine
kinase inhibitor imatinib, aromatase inhibitor letrozole reduce breast cancer tumor cell proliferation and
migration.
Conclusion: Current therapies target primarily the carcinoma cells, although many women have
recurrent disease or/and develop metastases. This study demonstrates the importance of tumor
microenvironment in mammary cancer development and the necessity to apply the treatment that will
includes both the stroma and the cancer cells.
Description:
Department of Histology, Cytology and Embryology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors